173 related articles for article (PubMed ID: 11920256)
1. Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura.
Malinowska I; Obitko-Płudowska A; Buescher ES; Wasik M; Rokicka-Milewska R
Hematol J; 2001; 2(4):242-9. PubMed ID: 11920256
[TBL] [Abstract][Full Text] [Related]
2. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
[TBL] [Abstract][Full Text] [Related]
3. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
4. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
[TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura.
Zimmerman SA; Malinoski FJ; Ware RE
Am J Hematol; 1998 Feb; 57(2):131-8. PubMed ID: 9462545
[TBL] [Abstract][Full Text] [Related]
6. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
[TBL] [Abstract][Full Text] [Related]
8. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
9. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
11. Plasma cytokine parameters and mortality in patients with chronic heart failure.
Rauchhaus M; Doehner W; Francis DP; Davos C; Kemp M; Liebenthal C; Niebauer J; Hooper J; Volk HD; Coats AJ; Anker SD
Circulation; 2000 Dec; 102(25):3060-7. PubMed ID: 11120695
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: the New York Hospital experience.
Scaradavou A
Semin Hematol; 2000 Jan; 37(1 Suppl 1):42-4. PubMed ID: 10676924
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes.
Alvarez B; Quinn LS; Busquets S; López-Soriano FJ; Argilés JM
Cancer Lett; 2002 Jan; 175(2):181-5. PubMed ID: 11741746
[TBL] [Abstract][Full Text] [Related]
18. Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.
Semple JW; Allen D; Rutherford M; Woloski M; David M; Wakefield C; Butchart S; Freedman J; Blanchette V;
Am J Hematol; 2002 Mar; 69(3):225-7. PubMed ID: 11891813
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Blanchette V; Carcao M
Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
